DOI : https://doi.org/10.56338/jphp.v6i3.11226

Effects of Moringa oleifera Leaf Extract on Serum 8-OHdG Levels in Alloxan-Induced Diabetic Rats

Yuhendri Putra (1), Arni Amir (2), Eti Yerizel (3), Hasmiwati (4)
(1) Doctoral Biomedical Program, Faculty of Medicine, Universitas Andalas, Padang, Sumatera Barat, Indonesia. Faculty of Nursing and Public Health, Universitas Prima Nusantara Bukittinggi, Sumatra Barat, Indonesia
(2) Faculty of Medicine, Universitas Andalas, Padang, Sumatera Barat, Indonesia
(3) Faculty of Medicine, Universitas Andalas, Padang, Sumatera Barat, Indonesia
(4) Faculty of Medicine, Universitas Andalas, Padang, Sumatera Barat, Indonesia
Fulltext View | Download
How to cite :
Putra, Y., Amir, A., Yerizel, E., & Hasmiwati. (2026). Effects of Moringa oleifera Leaf Extract on Serum 8-OHdG Levels in Alloxan-Induced Diabetic Rats. Journal of Public Health and Pharmacy, 6(3), 483–489. https://doi.org/10.56338/jphp.v6i3.11226
Citation Format :

Introduction: Oxidative stress contributes to the pathogenesis and complications of diabetes mellitus through excessive production of reactive oxygen species, which can lead to oxidative DNA damage. Serum 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) is widely used as a biomarker of oxidative DNA damage. Moringa oleifera leaves contain various antioxidant compounds that may help modulate oxidative stress under diabetic conditions. This study aimed to evaluate the effects of Moringa oleifera leaf extract on serum 8-OHdG levels in alloxan-induced diabetic rats.


Methods: This exploratory, randomized, post-test-only experiment included 25 male Wistar rats allocated to five groups (n = 5/group): non-diabetic control, alloxan-exposed diabetic control, and alloxan-exposed groups receiving Moringa oleifera leaf extract at 250, 500, or 1000 mg/kg body weight orally once daily for 14 days. Alloxan monohydrate was administered intraperitoneally at 150 mg/kg body weight. A fasting glucose level ≥200 mg/dL at 72 hours defined eligibility for the diabetic groups. Serum 8-OHdG was measured by enzyme-linked immunosorbent assay (ELISA), and group means were compared using one-way ANOVA with p < 0.05 as the significance threshold.


Results: Serum 8-OHdG did not differ significantly among groups (F(4,20) = 1.55; p = 0.227). The 500 mg/kg group had the numerically lowest mean (0.367 ± 0.036 ng/mL), but this observation did not establish a treatment effect or an optimal dose. The diabetic control mean (0.416 ± 0.073 ng/mL) was not higher than the non-diabetic control mean (0.468 ± 0.108 ng/mL).


Conclusion: This exploratory study did not demonstrate a statistically significant effect of Moringa oleifera leaf extract on serum 8-OHdG under the tested conditions. The observed numerical variation should be interpreted cautiously and does not establish antioxidant efficacy or an optimal dose. Larger, adequately powered studies with standardized extract characterization, longitudinal glycemic assessment, and additional oxidative stress markers are warranted.

  1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. Available from:https://diabetesatlas.org/resources/previous-editions/
  2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. DOI: https://doi.org/10.2337/diabetes.54.6.1615
  3. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070. DOI: https://doi.org/10.1161/CIRCRESAHA.110.223545
  4. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 5th ed. Oxford: Oxford University Press; 2015.
  5. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. DOI: https://doi.org/10.1152/physrev.00045.2011
  6. Valavanidis A, Vlachogianni T, Fiotakis C. 8-OHdG : a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27(2):120–139. DOI: https://doi.org/10.1080/10590500902885684
  7. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1–2):1–9. DOI: https://doi.org/10.1016/j.cccn.2003.09.010
  8. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567(1):1–61. DOI: https://doi.org/10.1016/j.mrrev.2003.11.001
  9. Forman HJ, Davies KJA, Ursini F. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging. Free Radic Biol Med. 2014;66:24–35. DOI: https://doi.org/10.1016/j.freeradbiomed.2013.05.045
  10. Bouayed J, Bohn T. Exogenous antioxidants—double-edged swords in cellular redox state. Oxid Med Cell Longev. 2010;3(4):228–237. DOI: https://doi.org/10.4161/oxim.3.4.12858
  11. Fahey JW. Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Trees Life J. 2005;1:5. Available from: https://moringafarms.com/wp-content/uploads/2014/05/Moringa-oleifera-A-Review-of-the-Medical-Evidence-for-Its-Nutritional-Therapeutic-and-Prophylactic-Properties.-Part-1.pdf
  12. Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res. 2007;21(1):17 25. DOI: https://doi.org/10.1002/ptr.2023
  13. Jaiswal D, Rai PK, Kumar A, Mehta S, Watal G. Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats. J Ethnopharmacol. 2009;123(3):392–396. DOI: https://doi.org/10.1016/j.jep.2009.03.036
  14. Mbikay M. Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia: a review. Front Pharmacol. 2012;3:24. DOI: https://doi.org/10.3389/fphar.2012.00024
  15. Vergara-Jimenez M, Almatrafi MM, Fernandez ML. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants (Basel). 2017;6(4):91. DOI: https://doi.org/10.3390/antiox6040091
  16. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol Res. 2001;50(6):536–546. Available from: https://www.biomed.cas.cz/physiolres/2001/issue6/pdf/szkudelski.pdf
  17. King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012;166(3):877–894. DOI: https://doi.org/10.1111/j.1476-5381.2012.01911.x
  18. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. DOI: https://doi.org/10.1371/journal.pbio.3000410
  19. Abd Eldaim MA, Shaban Abd Elrasoul A, Abd Elaziz SA. An aqueous extract from Moringa oleifera leaves ameliorates hepatotoxicity in alloxan-induced diabetic rats. Biochem Cell Biol. 2017;95(4):524–530. DOI: https://doi.org/10.1139/bcb-20160256
  20. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc. 2007;82(4):591–605. DOI: https://doi.org/10.1111/j.1469-185X.2007.00027.x
  21. Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–790. DOI: https://doi.org/10.1038/35008121
  22. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212(2):167–178. DOI: https://doi.org/10.1016/j.taap.2006.01.003
  23. Halliwell B. The antioxidant paradox: less paradoxical now? Br J Clin Pharmacol. 2013;75(3):637–644. DOI: https://doi.org/10.1111/j.1365-2125.2012.04272.x
  24. Calabrese EJ. Hormesis: path and progression to significance. Int J Mol Sci. 2018;19(10):2871. DOI: https://doi.org/10.3390/ijms19102871
  25. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365–376. DOI: https://doi.org/10.1038/nrn3475
  26. Mthiyane FT, Dludla PV, Ziqubu K, Mthembu SXH, Muvhulawa N, Hlengwa N, Nkambule BB, Mazibuko-Mbeje SE. A review on the antidiabetic properties of Moringa oleifera extracts: focusing on oxidative stress and inflammation as main therapeutic targets. Front Pharmacol. 2022;13:940572. DOI: https://doi.org/10.3389/fphar.2022.940572
  27. Leone A, Spada A, Battezzati A, Schiraldi A, Aristil J, Bertoli S. Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves: an overview. Int J Mol Sci. 2015;16(6):12791–12835. DOI: https://doi.org/10.3390/ijms160612791
  28. Gopalakrishnan L, Doriya K, Kumar DS. Moringa oleifera: a review on nutritive importance and its medicinal application. Food Sci Hum Wellness. 2016;5(2):49–56. DOI: https://doi.org/10.1016/j.fshw.2016.04.001
  29. Xu DP, Li Y, Meng X, Zhou T, Zhou Y, Zheng J, et al. Natural antioxidants in foods and medicinal plants: extraction, assessment and resources. Int J Mol Sci. 2017;18(1):96. DOI: https://doi.org/10.3390/ijms18010096
  30. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—a concise review. Saudi Pharm J. 2016;24(5):547–553. DOI: https://doi.org/10.1016/j.jsps.2015.03.013
  31. Rehman K, Akash MSH. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23:87. DOI: https://doi.org/10.1186/s12929-016-0303-y
  32. Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PIH Jr. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473(24):4527–4550. DOI: https://doi.org/10.1042/BCJ20160503C
  33. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9–19. DOI: https://doi.org/10.1097/WOX.0b013e3182439613
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:

  1. Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.

  2. Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.

  3. License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.

Downloads

Download data is not yet available.